Question 3099 — pharmacy and medications

Summary

Ms. Josette Manin questions the Minister of Solidarity and Health about bone marrow cancer - known as Kahler's disease or multiple myeloma. It is a rare and malignant disease that attacks the tissues contained in the bones where blood and lymph cells are produced. A particular cell, the plasma cell which is part of the white blood cells, is then infected and multiplies in an uncontrolled manner. This results in to invade the marrow at the expense of other blood cells, leading to the death of the patient. In France, where this disease affects nearly 30,000 people, the recommendations and work of the French-speaking Myeloma Intergroup (IFM) - made up of hematologists - have made it possible to find solutions for patients, thus creating real hope for them and their loved ones. Furthermore, since the end of 2015, the European Medicines Agency has issued marketing authorization for five new medicines (panobinostat, ixazomib, carfilzomib, daratumumab and elotuzumab) in Europe. These important steps should allow patients to continue to fight for their survival and their loved ones to maintain hope. However, the country is experiencing “slowness” in the administrative process of making these drugs available. Faced with this problem, she asks to inform him of the solutions that his administration intends to provide in the interest of patients.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.